Skip to Content
Severe eczema holding you back? Find the right treatment

Lindane topical Pregnancy and Breastfeeding Warnings

Lindane topical Pregnancy Warnings

There are no controlled data in human pregnancy; however, there is a single case report of a stillborn infant following multiple maternal exposures to this drug during pregnancy. The relationship of the maternal exposures to the fetal outcome is unknown. Animal data suggest this drug may increase the likelihood of neurologic developmental abnormalities, based on findings at systemic exposures close to that expected in humans. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: C Comments: This drug is lipophilic and may accumulate in the placenta.

See references

Lindane topical Breastfeeding Warnings

Animal data has revealed reduced pup survival, increased number of stillborn pups, increased pup mortality, decreased pup weight, increased motor activity, and decreased motor activity habituation when this drug was present in the diet from day 6 of gestation through day 10 of lactation.

Use of another agent is preferred during breastfeeding. Excreted into human milk: Yes Comments: -Topical application of this drug can increase drug levels in breastmilk for at least several days. -An environmental contaminant, this drug is potentially toxic in infants and has possible estrogenic effects that could decrease lactation as well as affect the nursing infant. -Advise breastfeeding patients to avoid large areas of skin-to-skin contact with their infants while the lotion formulation of this drug is applied, and to interrupt breastfeeding (including expression and discarding of milk) for at least 24 hours following use of this drug.

See references

References for pregnancy information

  1. "Product Information. Lindane (lindane topical)." VersaPharm Inc, Marietta, GA.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  2. "Product Information. Lindane (lindane topical)." VersaPharm Inc, Marietta, GA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide